• Feedback
  • RSS Feed
  • Sitemap
Ommcom News
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ
No Result
View All Result
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ
No Result
View All Result
Odisha News, Odisha Breaking News, Odisha Latest News || Ommcom News
Home Science & Tech

New Customised Drug Developed To Fight Aggressive Breast Cancer

OMMCOM NEWS by OMMCOM NEWS
May 22, 2024
in Science & Tech
Breast-Cancer

New Delhi: Using breast cancer cells’ weakness against themselves, UK scientists linked a tumour-selective antibody and developed a cell-killing drug that can destroy hard-to-treat tumours.

The findings, published on Wednesday in the journal Clinical Cancer Research, target triple-negative breast cancer — typically aggressive and resistant to chemotherapy and radiotherapy.

Accounting for up to 15 per cent of all diagnosed breast cancer, it also has a lower survival rate and is more common in women under 40.

To probe the properties of breast cancer cells linked to triple-negative breast cancer, a team from King’s College London conducted data analysis using over 6,000 breast cancer samples.

After understanding how the cancer cells escape from cancer drugs, they established the presence of the cancer cell surface marker EGFR along with oncogenic molecules cyclin-dependent kinases (CDK), which are responsible for cell division and proliferation.

Further, they linked cetuximab — a tumour-selective antibody that targets the EGFR protein expressed in this type of cancer, with a CDK-blocking drug to create a tailored drug for breast cancer.

“We were on the hunt for cancer’s vulnerabilities and now we’ve found out how we can guide our therapies to one of these. We combined these two drugs to create a tailored antibody-drug conjugate for patients with this aggressive cancer,” said lead author Professor Sophia Karagiannis, from King’s College London.

The researchers noted that as their “antibody-drug conjugate” targets the exact cancer cell, administering a lower inhibitor dose than usual may be possible, and will also be less toxic for the patient. They, however, called for more studies before developing the drug.

(IANS)

Tags: Breast Cancerlondon
ShareTweetSendSharePinShareSend
Previous Post

Malaysia Masters: Sindhu Beats Gilmour To Enter Rd-2; Mixed Pair Of Sumeeth-Sikki Also Prevails

Next Post

Why Regular Fish Oil Supplements Could Be Bad For Your Heart

Related Posts

Science & Tech

Centre Launches BharatGen To Create Ethical, Inclusive, Multilingual AI

June 2, 2025
Science & Tech

IIT Madras Study Shows Viruses Follow Seasonal And Yearly Cycles

June 2, 2025
Science & Tech

Indian Astronaut Shubhanshu Shukla To Conduct Key Food, Nutrition Experiments In Space

May 31, 2025
Science & Tech

Study Finds Common Gene Variant That Doubles Dementia Risk For Men

May 31, 2025
WHO
Science & Tech

Urgent Action Needed To Ban Flavoured Tobacco, Nicotine Products: WHO

May 30, 2025
Science & Tech

About 15 Pc Babies And Toddlers Facing Long-Covid, Symptoms Can Differ By Age: Study

May 29, 2025
Next Post
Vitamins

Why Regular Fish Oil Supplements Could Be Bad For Your Heart

CIPLA

Cipla Receives Final USFDA Nod For Lanreotide Injection To Treat Tumours

Suprem Court

SC Cancels Bail Of Eight Suspected Members Of Banned PFI

Khimji
  • Feedback
  • RSS Feed
  • Sitemap

© 2025 - Ommcom News. All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ

© 2025 - Ommcom News. All Rights Reserved.